Nanobiotix SA (NBTX)

CUSIP: 63009J107 | US | Healthcare · Biotechnology | Small Cap | 44 institutional holders

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13G/AInvus Public Equities, L.P.	4,828,374	9.4%	New 5%+ stake	Jun 30, 2026	No 13F filer matched
13G/AQatar Investment Authority	3,532,517	7.0%	New 5%+ stake	Jun 30, 2026	No 13F filer matched

13G/AInvus Public Equities, L.P.4,828,374

9.4% of class · Jun 30, 2026New 5%+ stake

No 13F filer matched

13G/AQatar Investment Authority3,532,517

7.0% of class · Jun 30, 2026New 5%+ stake

No 13F filer matched

Institutional Holders — Q3 2026

Sort by

Johnson & Johnson5,623,816

23.0% of portfolio$175.2M

Gamma Investing LLC1,134

0.0% of portfolio$35.3K

Lanark Financial, Inc.51

0.0% of portfolio$1.6K

Nisa Investment Advisors, LLC28

0.0% of portfolio$872

Physician Wealth Advisors, Inc.13

0.0% of portfolio$406

Citigroup Inc1

0.0% of portfolio$31

				Style	Turnover	Location	Filed
Johnson & Johnson	5,623,816	$175.2M	23.0%	Agg Growth	Very Low	New Brunswick, NJ	2026-10-26
Gamma Investing LLC	1,134	$35.3K	0.0%	Index	Very Low	Foster City, CA	2026-10-08
Lanark Financial, Inc.	51	$1.6K	0.0%	Core	Medium	Birmingham, AL	2026-10-26
Nisa Investment Advisors, LLC	28	$872	0.0%	Index	Very Low	St. Louis, MO	2026-10-20
Physician Wealth Advisors, Inc.	13	$406	0.0%	ETF	Medium	Midvale, UT	2026-10-20
Citigroup Inc	1	$31	0.0%	Core	Medium	New York, NY	2026-11-04